The expression of ATP2A1 in cholangiocarcinomas was significantly increased and correlated with the high immune state in the tumor microenvironment, which can be a high risk factor for the prognosis of patients (Lawal et al., 2021). This evidence concerns the gene ATP2A1 and cholangiocarcinoma.